Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 176 publications
Selective Internal Radiation Therapy (SIRT) for SDH-Deficient GIST Demonstrates Encouraging Durable Response Rates: An International Multicenter Case Series.
Journal: Cancers
Published: July 09, 2026
From Molecular Match to Surgical Decision: Precision Oncology Through a Surgical Lens.
Journal: Hematology/oncology clinics of North America
Published: June 17, 2026
Radiographic Versus Pathology-Integrated Response for Assessing Optimal Surgical Timing After Neoadjuvant Imatinib in Patients With Locally Advanced KIT Exon 11-Mutant GIST.
Journal: Annals of surgery
Published: April 06, 2026
NCCN Guidelines® Insights: Soft Tissue Sarcoma, Version 1.2025.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: February 11, 2026
Investigation of Profile-Related Evidence Determining Individualized Cancer Therapy (I-PREDICT) N-of-1 Precision Oncology Study: Molecular Profiling to Match Individually Dosed, Personalized Drug Combinations.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 08, 2026
Preoperative Avapritinib for Localized PDGFRA-Mutant GIST: Marked Pathologic Response, but Limited Feasibility at Standard Dosing.
Journal: Cancer medicine
Published: January 05, 2026
Management of multifocal and metastatic retroperitoneal sarcoma: an updated consensus approach from the transatlantic australasian retroperitoneal sarcoma working group (TARPSWG).
Journal: Cancer treatment reviews
Published: November 21, 2025
Cytoreductive Surgery in Patients With Metastatic Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumors.
Journal: Journal of surgical oncology
Published: November 16, 2025
Personalized N-of-1 Combination Therapies for Advanced Gastrointestinal Stromal Tumors.
Journal: JCO precision oncology
Published: July 23, 2025
GITR and GITR-L RNA Expression Levels Correlate with Better Survival and Response to Immunotherapy.
Journal: Molecular cancer therapeutics
Published: July 21, 2025
GITR and GITR-L RNA Expression Levels Correlate with Better Survival and Response to Immunotherapy.
Journal: Molecular cancer therapeutics
Published: July 21, 2025
Last Updated: 09/26/2026